Approval · Notice of Compliance 30882 · 2023
ASA: Notice of Compliance 30882
Issued June 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30882
- Date
- June 1, 2023
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling Update (to match Licensor)
- Canadian reference product
- ASPIRIN 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASA | Not yet assigned | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB